A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : IVIG / intravenous immunoglobulin

[Related PubMed/MEDLINE]
Total Number of Papers: 5398
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   IVIG  (>> Co-occurring Abbreviation)
Long Form:   intravenous immunoglobulin
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 "Double Trouble": Severe Meningoencephalitis Due to Borrelia burgdorferi and Powassan Virus Co-Infection Successfully Treated with Intravenous Immunoglobulin. POWV, POWV
2021 A 10-year cross-sectional retrospective study on Kawasaki disease in Iranian children: incidence, clinical manifestations, complications, and treatment patterns. CRP, KD
2021 A case of IVIg responsive paraneoplastic SOX1 peripheral neuropathy in a male with breast carcinoma. ---
2021 A Case of Severe Refractory Pemphigus Vulgaris in a Patient With Stable Esophageal Malignancy. PNP, PV
2021 A case report of atypical Kawasaki disease presented with severe elevated transaminases and literature review. CA, CRP, KD
2021 A clinician survey for management of the secondary immunodeficiency caused by hematological malignancies in China. Ig, SCIG, SID
2021 A nation-wide survey of Japanese pediatric MOG antibody-associated diseases. ADS, CS
2021 A Phase II Safety and Efficacy Study on Prognosis of Moderate Pneumonia in Coronavirus Disease 2019 Patients With Regular Intravenous Immunoglobulin Therapy. COVID-19, SOC
2021 A population-based analysis on the use of therapeutic plasma exchange and intravenous immunoglobulin in heparin-induced thrombocytopenia. HIT, NIS, TPE
10  2021 A prospective observational study of the incidence, natural history, and risk factors for intravenous immunoglobulin-mediated hemolysis. ---
11  2021 A Rare Case of Parvovirus B19 Infection Manifesting as Chronic Aplastic Anemia and Neutropenia in a Human Immunodeficiency Virus-Infected Patient. ANC, DNA, ED, HIV, IgM, MRSA, MSSA, PCR, PVB19
12  2021 A systemic review of intravenous immunoglobulin G treatment in women with recurrent implantation failures and recurrent pregnancy losses. RIFs, RPLs
13  2021 A unique association of bifacial weakness, paresthesia and vestibulocochlear neuritis as post-COVID-19 manifestation in pregnant women: a case report. BFP, GBS, WHO
14  2021 Acquired von Willebrand syndrome in monoclonal gammopathy - A scoping review on hemostatic management. AVWS, AVWS-MGUS, DDAVP, MGUS
15  2021 Acute development of syringomyelia following TBM in a pediatric case. TBM
16  2021 Acute Disseminated Encephalomyelitis Related to a Cytomegalovirus Infection in an Immunocompetent Patient. ADEM, CMV, CSF, FLAIR, IgG, IgM, MRI
17  2021 Acute Severe Thrombocytopenia Event Associated with Trimethoprim/Sulfamethoxazole Use. DITP, HIT, ITP, PTP, TMP/SMX, TTP
18  2021 Adjunctive intravenous immunoglobulins (IVIg) for moderate-severe COVID-19: emerging therapeutic roles. ---
19  2021 Alzheimer's Gone Viral: Could Herpes Simplex Virus Type-1 Be Stealing Your Memories? AD, HSV-1
20  2021 Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications. ELISA
21  2021 Anti-TIF1γ antibody-positive dermatomyositis associated with durvalumab administration in a patient with lung and oesophageal cancers. TIF1gamma
22  2021 Antibody Therapy: From Diphtheria to Cancer, COVID-19, and Beyond. mAbs
23  2021 Antibody-Mediated Rejection Management Following Lung Transplantation. AMR, DSAs
24  2021 Application of intravenous immunoglobulin (IVIG) to modulate inflammation in critical COVID-19 - A theoretical perspective. SARS-CoV-2
25  2021 Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children. MIS-C, OR
26  2021 Atypical inflammatory demyelinating syndrome with central and peripheral nerve involvement. AQP4, CCPD, CIDP, CMT, MOG, MS, OCBs
27  2021 Benefits of immunoglobulin substitution in primary and secondary immunodeficiencies: Interim analysis of a prospective, long-term non-interventional study. NIS, QoL
28  2021 Bilateral vocal fold paresis: the only presenting sign of anti-MUSK antibody myasthenia gravis. MuSK-MG
29  2021 Bioinformatics identification of hub genes and signaling pathways regulated by intravenous immunoglobulin treatment in acute Kawasaki disease. KD
30  2021 Biological stratification of clinical disease courses in childhood immune thrombocytopenia. ASR, CSR, IgG, ITP
31  2021 Boolean analysis of the transcriptomic data to identify novel biomarkers of IVIG response. KD
32  2021 Borrelia burgdorferi sensu lato seroconversion after intravenous immunoglobulin treatment: A cohort study. CIDP, IgG, IgM
33  2021 Bortezomib for treatment of anti-NMDA receptor encephalitis in a pediatric patient refractory to conventional therapy. CSF, NMDA
34  2021 Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination. CNS, CSF, MMF, MOG, MRI, NMDAR
35  2021 Case Report: Case Series of Children With Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Switzerland. KD, MAS, MIS-C, TSS
36  2021 Case Report: Improvement Following Immunotherapy in an Individual With Seronegative Down Syndrome Disintegrative Disorder. DSDD, MMF
37  2021 Case Report: Kidney Transplantation in a Patient With Acquired Agammaglobulinemia and SLE. Issues and Challenges. CMV, ESKD, SLE
38  2021 Case Report: PANDAS and Persistent Lyme Disease With Neuropsychiatric Symptoms: Treatment, Resolution, and Recovery. ---
39  2021 Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome. aPL, APS, mAb
40  2021 Case Report: Splenic Irradiation for the Treatment of Chronic Active Antibody-Mediated Rejection in Kidney Allograft Recipients With De Novo Donor-Specific Antibodies. AMR, DSA, PP
41  2021 Case Report: Successful Response to Intravenous Immunoglobulin and Steroid Pulses in a Renal Transplant Recipient With Severe Covid-19 Disease and Associated Acute Allograft Failure. ---
42  2021 Case Report: Use of Anakinra in Multisystem Inflammatory Syndrome During COVID-19 Pandemic. PIMS-TS
43  2021 Cellular Immune Response to COVID-19 and Potential Immune Modulators. COVID-19, IFN, LMWH, SARS-CoV-2
44  2021 Cervical abscess caused by methicillin-susceptible Staphylococcus aureus in an infant infected with SARS-CoV-2: Diagnostic dilemma. MIS-C
45  2021 Challenges in Treating Statin-Associated Necrotizing Myopathy. CK
46  2021 Characterization of antibodies in human immunoglobulin products from different regions worldwide. ---
47  2021 Childhood-Onset Multifocal Motor Neuropathy with IgM Antibodies to Gangliosides GM1: A Case Report with Poor Outcome. EFNS/PNS
48  2021 Chronic enteropathy-related malabsorption syndrome in an adult with common variable immunodeficiency and symptomatic norovirus infection of the gut. CVID
49  2021 Chronic low-dose intravenous immunoglobulins as steroid-sparing therapy in myasthenia gravis. MG, MGFA
50  2021 Clinical and Genetic Profile of X-Linked Agammaglobulinemia: A Multicenter Experience From India. ESID, FPID
51  2021 Clinical Aspects of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis With Severe Ocular Complications in South Korea. CM, PTGER3, SJS, SNP, SOCs, TEN
52  2021 Clinical Characteristics and Predictors of Short-Term Outcome in Mexican Adult Patients with Guillain-Barré Syndrome. GBS
53  2021 Clinical characteristics of severe neonatal enterovirus infection: a systematic review. ECMO, EV
54  2021 Clinical efficacy of plasma exchange in patients with autoimmune encephalitis. AE, TPE
55  2021 Clinical experience with biologic treatment in resistant eosinophilic fasciitis: Case reports and review of the literature. EF, MTX
56  2021 Clinical Features of Patients with Active Eosinophilic Granulomatosis with Polyangiitis Successfully Treated with Mepolizumab. BVASs, EGPA
57  2021 Clinical implications of procalcitonin in Kawasaki disease: a useful candidate for differentiating from sepsis and evaluating IVIG responsiveness. CAAs, KD, PCT
58  2021 Clinical Profile and Outcome of Childhood Autoimmune Hemolytic Anemia: A Single Center Study. AIHA, DAT
59  2021 Clinical spectrum, outcome and management of immune thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia. CMML, ITP, MDS
60  2021 Clinical use of intravenous immunoglobulin in Taiwan: A 10-year population study. NHI
61  2021 Combination Rituximab and IVIG for Treatment of Refractory Vasculitic Neuropathy: A Case Series. GPA, NSVN
62  2021 Comparative Evaluation of the Treatment of COVID-19 with Multicriteria Decision-Making Techniques. COVID-19, FPV, MCDM
63  2021 Comparison of IVIG resistance predictive models in Kawasaki disease. ---
64  2021 Cost per response analysis of repository corticotropin injection versus other alternative treatments for acute exacerbations of multiple sclerosis. MS, OWSA, PMP, RCI, US
66  2021 Cryptosporidiosis - A Plausible Cause for Relapse of Guillain-Barré Syndrome. CSF, GBS
67  2021 Cyclophosphamide as a Treatment for Focal Segmental Glomerular Sclerosis Recurrence in a Kidney Transplant Patient. FSGS
68  2021 Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature. AIC, CD40L, HSCT, LRBA
69  2021 Demyelinating polyneuropathy associated with chronic inactive hepatitis B infection. CIDP, HBV
70  2021 Desquamation in Kawasaki Disease. CAA, KD
71  2021 Diffuse exanthematous drug eruption associated with intravenous immunoglobulin. ---
72  2021 Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial. ARDS, COVID-19, ICU, SOFA
73  2021 Effect of intravenous immunoglobulins to postpone the gestational age of first intrauterine transfusion in very severe red blood cell alloimmunization: A case-control study. GA, IUT, RBC, WG
74  2021 Effectiveness of Intravenous Immunoglobulin for Management of Pain in Patients with Postpolio Syndrome. PPS
75  2021 Efficacy and safety of intravenous immunoglobulins for the treatment of viral encephalitis: a systematic literature review. ---
76  2021 Efficacy evaluation of intravenous immunoglobulin in non-severe patients with COVID-19: A retrospective cohort study based on propensity score matching. COVID-19, PSM
77  2021 Efficacy of Intravenous Immunoglobulin for Preventing Infections in Patients with Multiple Myeloma. CI, IEs, IRR, MM, PD
78  2021 Evaluation of Intravenous Immunoglobulin in Pediatric Acute-Onset Neuropsychiatric Syndrome. CY-BOCS, PANS, PANS Scale
79  2021 Evaluation of the risk factors predicting thrombotic complications associated with intravenous immunoglobulin therapy in neuroimmunological diseases. mRS, TCI
80  2021 Exacerbating Guillain-Barré Syndrome Eight Days after Vector-Based COVID-19 Vaccination. GBS
81  2021 Failure of IVIG in steroid-responsive autoimmune glial fibrillary acidic protein astrocytopathy: A case report. GFAP
82  2021 Family Transmission of COVID-19 Including a Child with MIS-C and Acute Pancreatitis. MIS-C
83  2021 Functional outcomes following inpatient rehabilitation of guillain-barré syndrome patients: Intravenous immunoglobulins versus plasma exchange. ADL, FIM, GBS, GDS, PE, REs, REy
84  2021 Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy. CI, CIDP, OR
85  2021 High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China. COVID-19, IPTW, MI
86  2021 Higher efficacy of infliximab than immunoglobulin on Kawasaki disease, a meta-analysis. AEs, CI, KD, OR
87  2021 Homozygous of MRP4 Gene rs1751034 C Allele Is Related to Increased Risk of Intravenous Immunoglobulin Resistance in Kawasaki Disease. CI, KD, MRP4, OR
88  2021 How IvIg Can Mitigate Covid-19 Disease: A Symmetrical Immune Network Model. SARS-CoV-2
89  2021 HSV encephalitis triggered anti-NMDAR encephalitis: a case report. HSE, NMDAR
90  2021 Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity. CIPN, IENF, PIPN, PTX
91  2021 Human parvovirus B19-associated early postoperative acquired pure red cell aplasia in simultaneous pancreas-kidney transplantation: A case report. aPRCA, EC-MPS, Hb, HPV B19, mNGS, POD, SPKT
92  2021 Immune Checkpoint Inhibitor-related Guillain-Barré Syndrome: A Case Series and Review of the Literature. GBS, ICIs
93  2021 Immune Computation and COVID-19 Mortality: A Rationale for IVIg. ---
94  2021 Immune reactivity during COVID-19: Implications for treatment. ARDS, CRP, HLA-DR, MAS, NK
95  2021 Immune thrombocytopenia and COVID-19: Case report and review of literature. ITP
96  2021 Immune-Based Therapy for COVID-19. COVID-19, SARS-CoV-2
97  2021 Immunoadsorption for heart failure is associated with normalization of iron metabolism. HF, HFrEF, LVEF
98  2021 Immunoglobulin therapy for successful management of prolonged, recurrent jaundice in a young adult male with combined immunodeficiency. CID, NK
99  2021 Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider. EULAR, RCTs
100  2021 Immunomodulatory treatment in postural tachycardia syndrome: A case series. POTS